- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Environmentally-Friendly
Hong Kong Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Feb 18, 2024
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
99 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 6990Sichuan Kelun-Biotech Biopharmaceutical | HK$96.60 | 17.1% | n/a | HK$21.0b | HK$122.30 | PS12.9x | E17.2% | n/a | ||
| 2315Biocytogen Pharmaceuticals (Beijing) | HK$7.10 | -17.8% | -72.1% | HK$3.5b | HK$19.03 | PS4.1x | E91.8% | n/a | ||
| 1801Innovent Biologics | HK$38.75 | 7.6% | -6.5% | HK$65.1b | HK$55.01 | PS11.5x | E50.5% | n/a | ||
| 9995RemeGen | HK$19.00 | 11.8% | -65.9% | HK$21.8b | HK$53.31 | PS9.7x | E57.3% | n/a | ||
| 1061Essex Bio-Technology | HK$2.34 | -1.7% | -44.0% | HK$1.4b | HK$5.12 | PE5.2x | E24.9% | 3.0% | ||
| 460Sihuan Pharmaceutical Holdings Group | HK$0.55 | 0% | -43.9% | HK$5.2b | n/a | PS2.7x | E119.4% | 0% | ||
| 2005SSY Group | HK$4.21 | 3.4% | -12.3% | HK$12.4b | HK$5.99 | PE10.5x | E20.4% | 3.6% | ||
| 1548Genscript Biotech | HK$13.56 | 1.2% | -40.7% | HK$29.7b | HK$30.56 | PS5.2x | E62.4% | 0% | ||
| 2268WuXi XDC Cayman | HK$14.14 | -3.4% | n/a | HK$17.1b | HK$40.19 | PE65.3x | E35.0% | n/a | ||
| 570China Traditional Chinese Medicine Holdings | HK$3.43 | 0% | -20.0% | HK$17.3b | HK$4.33 | PE17.1x | E22.9% | 1.4% | ||
| 1521Frontage Holdings | HK$1.79 | 3.5% | -33.5% | HK$3.7b | HK$2.25 | PE26.7x | E25.6% | n/a | ||
| 2696Shanghai Henlius Biotech | HK$12.76 | -0.6% | -12.7% | HK$7.1b | HK$17.55 | PE115.9x | E51.4% | n/a | ||
| 6826Shanghai Haohai Biological Technology | HK$35.00 | 1.7% | -23.9% | HK$17.2b | HK$70.01 | PE15.5x | E25.4% | 1.2% | ||
| 1558YiChang HEC ChangJiang Pharmaceutical | HK$8.79 | 3.0% | 16.1% | HK$7.8b | HK$11.12 | PE6.2x | E32.0% | 0% | ||
| 2186Luye Pharma Group | HK$2.68 | 5.1% | -28.5% | HK$10.4b | HK$3.40 | PE20.3x | E16.6% | n/a | ||
| 6600SciClone Pharmaceuticals (Holdings) | HK$12.56 | 12.7% | 25.3% | HK$7.3b | HK$15.83 | PE7.4x | E7.9% | 3.0% | ||
| 2269WuXi Biologics (Cayman) | HK$16.60 | -4.2% | -71.6% | HK$72.2b | HK$51.46 | PE15.4x | E17.5% | n/a | ||
| 3320China Resources Pharmaceutical Group | HK$5.12 | 0.6% | -23.0% | HK$32.1b | HK$7.72 | PE7.7x | E13.8% | 3.1% | ||
| 2480Beijing Luzhu Biotechnology | HK$27.00 | -5.4% | n/a | HK$5.7b | HK$38.19 | PB4.4x | E13.5% | n/a | ||
| 2171CARsgen Therapeutics Holdings | HK$4.93 | 9.1% | -71.4% | HK$2.8b | HK$9.98 | PB1.2x | E12.7% | n/a | ||
| 2552Hua Medicine (Shanghai) | HK$1.60 | 1.3% | -62.8% | HK$1.7b | HK$3.29 | PS16.4x | E19.9% | n/a | ||
| 6628Transcenta Holding | HK$2.49 | -15.6% | -4.2% | HK$1.1b | HK$8.48 | PS8.2x | E2.3% | n/a | ||
| 1477Ocumension Therapeutics | HK$5.05 | 1.8% | -56.2% | HK$3.5b | HK$11.66 | PS15.5x | E47.8% | n/a | ||
| 6855Ascentage Pharma Group International | HK$25.25 | 15.3% | -6.5% | HK$7.1b | HK$32.30 | PS25.8x | E23.8% | n/a |